Franklin Genomic Advancements ETF

HELXCBOE · USD
43.10USD0.00 (+0.63%)

Franklin Genomic Advancements ETF (HELX) Option Chain

As of September 21, 2026, Franklin Genomic Advancements ETF is trading at $43.10, a +0.63% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 31.6%. IV Rank is 33%.

Read more

Tracking the HELX option chain helps you see every strike and expiry on Franklin Genomic Advancements ETF in one view, so you can quickly identify the contracts that fit your thesis and your risk. Franklin Genomic Advancements ETF's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HELX options activity at a glance. Use our scanner to monitor the HELX option chain in real time and filter for the HELX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HELX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the HELX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where HELX stock options are being actively traded and where they are not.

The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Franklin Genomic Advancements ETF's full chain across every expiry, highlights the most liquid strikes, and lets you screen HELX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of HELX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV percentile18.25% Subdued
  • Market cap (M$)
  • 52 weeks high-0.94%
  • 52 weeks low44.63%
  • Analyst recommendation
  • Target price
  • Dividend
  • Payout ratio
  • Earnings date
  • P/E
  • Future P/E
  • EPS (ttm)
  • EPS growth next 5 years

As of September 21, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
27.42000.372.100.854.1041.00-4.870.201.800.001.000072.58
37.95000.621.100.153.3042.00-2.552.050.002.050062.05
49.20002.550.102.6543.00-0.232.450.002.450050.80
60.26002.150.002.1544.00+2.093.000.902.100039.74
70.33001.900.001.9045.00+4.410.603.801.900.300029.67

As of September 21, 2026

Scan the full option chain in one place

Browse the full HELX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial